Gallbladder biliary intraepithelial neoplasia

Summary

Gallbladder biliary intraepithelial neoplasia (MONDO:0006218) is a disease. A subtype of gallbladder neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	gallbladder biliary intraepithelial neoplasia
Mondo ID	MONDO:0006218
EFO	EFO:1000265
NCIT	C43606
UMLS	C1708174
MedGen	317714
Is cancer (heuristic)	no

Also known as: gallbladder biliary intraepithelial neoplasia · gallbladder BilIN · gallbladder dysplasia · gallbladder intraepithelial neoplasia · intracystic biliary intraepithelial neoplasia · intracystic BilIN

Disease family

This is a subtype of gallbladder neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › hepatobiliary disorder › hepatobiliary neoplasm › gallbladder neoplasm › gallbladder biliary intraepithelial neoplasia

Related subtypes (5): gallbladder papillary neoplasm, gallbladder cancer, gallbladder adenoma, benign neoplasm of gallbladder, gallbladder neuroendocrine neoplasm

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.